In L02 cells, PA treatment notably intensified steatosis levels, elevated TRIM59 expression, and enhanced the secretion of tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and interleukin 8 (IL-8). The gene discussed is TRIM59; the disease is steatosis.